Predict your next investment

HEALTHCARE | Biotechnology

See what CB Insights has to offer

Founded Year



Series B | Alive

Total Raised


Last Raised

$8M | 16 yrs ago

About InterGenetics

Provider of predictive, genetics-based cancer assessments. The company uses proprietary gene combinations and DNA assessment technology to identify women who are at high risk of developing breast cancer. Its research pipeline of predictive based testing has future applications in predicting heart disease, diabetes and other cancer types such as ovarian, colon, prostate, and pancreatic.

InterGenetics Headquarter Location

655 Research Parkway Suite 300

Oklahoma City, Oklahoma, 73104,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing InterGenetics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

InterGenetics is included in 1 Expert Collection, including Diabetes.



1,734 items

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.